Literature DB >> 19929814

The critical role of the endocannabinoid system in emotional homeostasis: avoiding excess and deficiencies.

E M Marco1, M P Viveros.   

Abstract

The endocannabinoid system is critical in the regulation of emotion and stress responsiveness. Despite the promising therapeutic value of its pharmacological modulation, deficient and excessive endocannabinoid signalling should be avoided. This mini-review will provide an up-to-date revision on this topic, emphasizing the relevance of a normative endocannabinoid system for emotional homeostasis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19929814     DOI： 10.2174/138955709789957468

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN： 1389-5575            Impact factor:   3.862


  13 in total

1.  The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats.

Authors:  Mano Aliczki; Istvan Barna; Ibolya Till; Maria Baranyi; Beata Sperlagh; Steven R Goldberg; Jozsef Haller
Journal:  Psychopharmacology (Berl)       Date:  2016-01-26       Impact factor: 4.530

2.  Repeated restraint stress alters sensitivity to the social consequences of ethanol in adolescent and adult rats.

Authors:  Elena I Varlinskaya; Tamara L Doremus-Fitzwater; Linda P Spear
Journal:  Pharmacol Biochem Behav       Date:  2010-05-15       Impact factor: 3.533

Review 3.  Neurobiological Interactions Between Stress and the Endocannabinoid System.

Authors:  Maria Morena; Sachin Patel; Jaideep S Bains; Matthew N Hill
Journal:  Neuropsychopharmacology       Date:  2015-06-12       Impact factor: 7.853

Review 4.  Framework for sex differences in adolescent neurobiology: a focus on cannabinoids.

Authors:  Maria-Paz Viveros; Eva M Marco; Meritxell López-Gallardo; Luis Miguel Garcia-Segura; Edward J Wagner
Journal:  Neurosci Biobehav Rev       Date:  2010-09-30       Impact factor: 8.989

5.  The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats.

Authors:  Jozsef Haller; Steven R Goldberg; Katalin Gyimesine Pelczer; Mano Aliczki; Leigh V Panlilio
Journal:  Psychopharmacology (Berl)       Date:  2013-06-07       Impact factor: 4.530

6.  Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.

Authors:  Eva M Marco; María S García-Gutiérrez; Francisco-Javier Bermúdez-Silva; Fabricio A Moreira; Francisco Guimarães; Jorge Manzanares; María-Paz Viveros
Journal:  Front Behav Neurosci       Date:  2011-10-05       Impact factor: 3.558

7.  Altering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance.

Authors:  Viviana Trezza; Patrizia Campolongo; Antonia Manduca; Maria Morena; Maura Palmery; Louk J M J Vanderschuren; Vincenzo Cuomo
Journal:  Front Behav Neurosci       Date:  2012-01-24       Impact factor: 3.558

8.  Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit.

Authors:  Ana Belen Lopez-Rodriguez; Estefania Acaz-Fonseca; Maria-Paz Viveros; Luis M Garcia-Segura
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

Review 9.  Cannabis and psychopathology: The meandering journey of the last decade.

Authors:  Abhishek Ghosh; Debasish Basu
Journal:  Indian J Psychiatry       Date:  2015 Apr-Jun       Impact factor: 1.759

10.  The Role of the Endocannabinoids in Suppression of the Hypothalamic-pituitary-adrenal Axis Activity by Doxepin.

Authors:  Parichehr Hassanzadeh; Anna Hassanzadeh
Journal:  Iran J Basic Med Sci       Date:  2011-09       Impact factor: 2.699
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.